These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease. Elbarbary NS; Ismail EA; Roushdy A; Fahmy E Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648 [TBL] [Abstract][Full Text] [Related]
26. [A new method quantifying tricuspid regurgitant volume by two-dimensional color and continuous wave Doppler echocardiography]. Sugimoto T; Ota T; Nakamura K J Cardiol; 1988 Dec; 18(4):1069-81. PubMed ID: 3267716 [TBL] [Abstract][Full Text] [Related]
27. Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease. Liem RI; Nevin MA; Prestridge A; Young LT; Thompson AA Pediatr Pulmonol; 2009 Mar; 44(3):281-9. PubMed ID: 19205056 [TBL] [Abstract][Full Text] [Related]
28. Frequency of pulmonary hypertension in asymptomatic β-thalassemia major patients and the role of physiological parameters in evaluation. Kiter G; Balci YI; Ates A; Hacioglu S; Sari I Pediatr Hematol Oncol; 2010 Nov; 27(8):597-607. PubMed ID: 20795768 [TBL] [Abstract][Full Text] [Related]
29. A hemodynamic study of pulmonary hypertension in sickle cell disease. Parent F; Bachir D; Inamo J; Lionnet F; Driss F; Loko G; Habibi A; Bennani S; Savale L; Adnot S; Maitre B; Yaïci A; Hajji L; O'Callaghan DS; Clerson P; Girot R; Galacteros F; Simonneau G N Engl J Med; 2011 Jul; 365(1):44-53. PubMed ID: 21732836 [TBL] [Abstract][Full Text] [Related]
30. Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia. Derchi G; Musallam KM; Pinto VM; Graziadei G; Giuditta M; Barella S; Origa R; Casu G; Pasanisi A; Longo F; Casale M; Miceli R; Merella P; Gianesin B; Ameri P; Tartaglione I; Perrotta S; Piga A; Cappellini MD; Forni GL Haematologica; 2022 Jul; 107(7):1714-1718. PubMed ID: 35236055 [No Abstract] [Full Text] [Related]
31. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype. Landburg PP; Teerlink T; Biemond BJ; Brandjes DP; Muskiet FA; Duits AJ; Schnog JB; Blood Cells Mol Dis; 2010 Apr; 44(4):229-32. PubMed ID: 20185345 [TBL] [Abstract][Full Text] [Related]
32. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. Gladwin MT; Sachdev V; Jison ML; Shizukuda Y; Plehn JF; Minter K; Brown B; Coles WA; Nichols JS; Ernst I; Hunter LA; Blackwelder WC; Schechter AN; Rodgers GP; Castro O; Ognibene FP N Engl J Med; 2004 Feb; 350(9):886-95. PubMed ID: 14985486 [TBL] [Abstract][Full Text] [Related]
33. Pulmonary hypertension risk in patients with hemoglobin h disease: low incidence and absence of correlation with splenectomy. Yin XL; Zhang XH; Wu ZK; Zhao DH; Zhou YL; Yu YH; Liu TN; Fang SP; Zhou TH; Wang L; Huang J Acta Haematol; 2013; 130(3):153-9. PubMed ID: 23711936 [TBL] [Abstract][Full Text] [Related]
34. Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy. El-Beshlawy A; Youssry I; El-Saidi S; El Accaoui R; Mansi Y; Makhlouf A; Taher A Pediatr Hematol Oncol; 2008 Dec; 25(8):734-43. PubMed ID: 19065439 [TBL] [Abstract][Full Text] [Related]
35. Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: less prevalent and predictive than previously thought? Hebson C; New T; Record E; Oster M; Ehrlich A; Border W; James-Herry A; Kanaan U J Pediatr Hematol Oncol; 2015 Mar; 37(2):134-9. PubMed ID: 24942020 [TBL] [Abstract][Full Text] [Related]
36. Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension. van Beers EJ; van Eck-Smit BL; Mac Gillavry MR; van Tuijn CF; van Esser JW; Brandjes DP; Kappers-Klunne MC; Duits AJ; Biemond BJ; Schnog JJ; Chest; 2008 Mar; 133(3):646-52. PubMed ID: 18198257 [TBL] [Abstract][Full Text] [Related]
37. Doppler-defined pulmonary hypertension in β-thalassemia major in Kurdistan, Iraq. Mohammad AM; Dawad MM; Kashmoola MA; Al-Allawi N PLoS One; 2020; 15(12):e0243648. PubMed ID: 33301537 [TBL] [Abstract][Full Text] [Related]
38. Splenectomy is not associated with a higher tricuspid regurgitant jet velocity in people with sickle cell anemia. Sinha AA; Adusumilli T; Cohen HW; Nouraie M; Little J; Manwani D Pediatr Blood Cancer; 2019 Oct; 66(10):e27928. PubMed ID: 31322833 [TBL] [Abstract][Full Text] [Related]
39. Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance. Chaudry RA; Cikes M; Karu T; Hutchinson C; Ball S; Sutherland G; Rosenthal M; Bush A; Crowley S Arch Dis Child; 2011 Feb; 96(2):131-6. PubMed ID: 21030373 [TBL] [Abstract][Full Text] [Related]
40. Increased tricuspid regurgitant jet velocity by Doppler echocardiography in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. Armstrong GT; Joshi VM; Zhu L; Srivastava D; Zhang N; Ness KK; Stokes DC; Krasin MT; Fowler JA; Robison LL; Hudson MM; Green DM J Clin Oncol; 2013 Feb; 31(6):774-81. PubMed ID: 23295810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]